<?xml version="1.0" encoding="UTF-8" standalone="no"?><document id="DDI-DrugBank.d186">
    <sentence id="DDI-DrugBank.d186.s0" text="An encephalopathic syndrome (characterized by weakness, lethargy, fever, tremulousness and confusion, extrapyramidal symptoms, leukocytosis, elevated serum enzymes, BUN, and FBS) followed by irreversible brain damage has occurred in a few patients treated with lithium plus HALDOL.">
        <entity charOffset="261-267" id="DDI-DrugBank.d186.s0.e0" text="lithium" type="drug"/>
        <entity charOffset="274-279" id="DDI-DrugBank.d186.s0.e1" text="HALDOL" type="brand"/>
        <pair ddi="true" e1="DDI-DrugBank.d186.s0.e0" e2="DDI-DrugBank.d186.s0.e1" id="DDI-DrugBank.d186.s0.p0" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d186.s1" text="A causal relationship between these events and the concomitant administration of lithium and HALDOL has not been established;">
        <entity charOffset="81-87" id="DDI-DrugBank.d186.s1.e0" text="lithium" type="drug"/>
        <entity charOffset="93-98" id="DDI-DrugBank.d186.s1.e1" text="HALDOL" type="brand"/>
        <pair ddi="false" e1="DDI-DrugBank.d186.s1.e0" e2="DDI-DrugBank.d186.s1.e1" id="DDI-DrugBank.d186.s1.p0"/>
    <negationtags>A causal relationship between these events and the concomitant administration of lithium and HALDOL has &lt;scope&gt; &lt;cue&gt; not &lt;/cue&gt; been established; &lt;/scope&gt;</negationtags></sentence>
    <sentence id="DDI-DrugBank.d186.s2" text="however, patients receiving such combined therapy should be monitored closely for early evidence of neurological toxicity and treatment discontinued promptly if such signs appear."/>
    <sentence id="DDI-DrugBank.d186.s3" text="As with other antipsychotic agents, it should be noted that HALDOL may be capable of potentiating CNS depressants such as anesthetics, opiates, and alcohol.">
        <entity charOffset="14-33" id="DDI-DrugBank.d186.s3.e0" text="antipsychotic agents" type="group"/>
        <entity charOffset="60-65" id="DDI-DrugBank.d186.s3.e1" text="HALDOL" type="brand"/>
        <entity charOffset="98-112" id="DDI-DrugBank.d186.s3.e2" text="CNS depressants" type="group"/>
        <entity charOffset="122-132" id="DDI-DrugBank.d186.s3.e3" text="anesthetics" type="group"/>
        <entity charOffset="135-141" id="DDI-DrugBank.d186.s3.e4" text="opiates" type="group"/>
        <entity charOffset="148-154" id="DDI-DrugBank.d186.s3.e5" text="alcohol" type="drug"/>
        <pair ddi="false" e1="DDI-DrugBank.d186.s3.e0" e2="DDI-DrugBank.d186.s3.e1" id="DDI-DrugBank.d186.s3.p0"/>
        <pair ddi="true" e1="DDI-DrugBank.d186.s3.e0" e2="DDI-DrugBank.d186.s3.e2" id="DDI-DrugBank.d186.s3.p1" type="effect"/>
        <pair ddi="true" e1="DDI-DrugBank.d186.s3.e0" e2="DDI-DrugBank.d186.s3.e3" id="DDI-DrugBank.d186.s3.p2" type="effect"/>
        <pair ddi="true" e1="DDI-DrugBank.d186.s3.e0" e2="DDI-DrugBank.d186.s3.e4" id="DDI-DrugBank.d186.s3.p3" type="effect"/>
        <pair ddi="true" e1="DDI-DrugBank.d186.s3.e0" e2="DDI-DrugBank.d186.s3.e5" id="DDI-DrugBank.d186.s3.p4" type="effect"/>
        <pair ddi="true" e1="DDI-DrugBank.d186.s3.e1" e2="DDI-DrugBank.d186.s3.e2" id="DDI-DrugBank.d186.s3.p5" type="effect"/>
        <pair ddi="true" e1="DDI-DrugBank.d186.s3.e1" e2="DDI-DrugBank.d186.s3.e3" id="DDI-DrugBank.d186.s3.p6" type="effect"/>
        <pair ddi="true" e1="DDI-DrugBank.d186.s3.e1" e2="DDI-DrugBank.d186.s3.e4" id="DDI-DrugBank.d186.s3.p7" type="effect"/>
        <pair ddi="true" e1="DDI-DrugBank.d186.s3.e1" e2="DDI-DrugBank.d186.s3.e5" id="DDI-DrugBank.d186.s3.p8" type="effect"/>
        <pair ddi="false" e1="DDI-DrugBank.d186.s3.e2" e2="DDI-DrugBank.d186.s3.e3" id="DDI-DrugBank.d186.s3.p9"/>
        <pair ddi="false" e1="DDI-DrugBank.d186.s3.e2" e2="DDI-DrugBank.d186.s3.e4" id="DDI-DrugBank.d186.s3.p10"/>
        <pair ddi="false" e1="DDI-DrugBank.d186.s3.e2" e2="DDI-DrugBank.d186.s3.e5" id="DDI-DrugBank.d186.s3.p11"/>
        <pair ddi="false" e1="DDI-DrugBank.d186.s3.e3" e2="DDI-DrugBank.d186.s3.e4" id="DDI-DrugBank.d186.s3.p12"/>
        <pair ddi="false" e1="DDI-DrugBank.d186.s3.e3" e2="DDI-DrugBank.d186.s3.e5" id="DDI-DrugBank.d186.s3.p13"/>
        <pair ddi="false" e1="DDI-DrugBank.d186.s3.e4" e2="DDI-DrugBank.d186.s3.e5" id="DDI-DrugBank.d186.s3.p14"/>
    </sentence>
    <sentence id="DDI-DrugBank.d186.s4" text="In a study of 12 schizophrenic patients coadministered oral haloperidol and rifampin, plasma haloperidol levels were decreased by a mean of 70% and mean scores on the Brief Psychiatric Rating Scale were increased from baseline.">
        <entity charOffset="60-70" id="DDI-DrugBank.d186.s4.e0" text="haloperidol" type="drug"/>
        <entity charOffset="76-83" id="DDI-DrugBank.d186.s4.e1" text="rifampin" type="drug"/>
        <entity charOffset="93-103" id="DDI-DrugBank.d186.s4.e2" text="haloperidol" type="drug"/>
        <pair ddi="true" e1="DDI-DrugBank.d186.s4.e0" e2="DDI-DrugBank.d186.s4.e1" id="DDI-DrugBank.d186.s4.p0" type="mechanism"/>
        <pair ddi="false" e1="DDI-DrugBank.d186.s4.e0" e2="DDI-DrugBank.d186.s4.e2" id="DDI-DrugBank.d186.s4.p1"/>
        <pair ddi="false" e1="DDI-DrugBank.d186.s4.e1" e2="DDI-DrugBank.d186.s4.e2" id="DDI-DrugBank.d186.s4.p2"/>
    </sentence>
    <sentence id="DDI-DrugBank.d186.s5" text="In 5 other schizophrenic patients treated with oral haloperidol and rifampin, discontinuation of rifampin produced a mean 3.3-fold increase in haloperidol concentrations.">
        <entity charOffset="52-62" id="DDI-DrugBank.d186.s5.e0" text="haloperidol" type="drug"/>
        <entity charOffset="68-75" id="DDI-DrugBank.d186.s5.e1" text="rifampin" type="drug"/>
        <entity charOffset="97-104" id="DDI-DrugBank.d186.s5.e2" text="rifampin" type="drug"/>
        <entity charOffset="143-153" id="DDI-DrugBank.d186.s5.e3" text="haloperidol" type="drug"/>
        <pair ddi="false" e1="DDI-DrugBank.d186.s5.e0" e2="DDI-DrugBank.d186.s5.e1" id="DDI-DrugBank.d186.s5.p0"/>
        <pair ddi="false" e1="DDI-DrugBank.d186.s5.e0" e2="DDI-DrugBank.d186.s5.e2" id="DDI-DrugBank.d186.s5.p1"/>
        <pair ddi="false" e1="DDI-DrugBank.d186.s5.e0" e2="DDI-DrugBank.d186.s5.e3" id="DDI-DrugBank.d186.s5.p2"/>
        <pair ddi="false" e1="DDI-DrugBank.d186.s5.e1" e2="DDI-DrugBank.d186.s5.e2" id="DDI-DrugBank.d186.s5.p3"/>
        <pair ddi="false" e1="DDI-DrugBank.d186.s5.e1" e2="DDI-DrugBank.d186.s5.e3" id="DDI-DrugBank.d186.s5.p4"/>
        <pair ddi="true" e1="DDI-DrugBank.d186.s5.e2" e2="DDI-DrugBank.d186.s5.e3" id="DDI-DrugBank.d186.s5.p5" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d186.s6" text="Thus, careful monitoring of clinical status is warranted when rifampin is administered or discontinued in haloperidol-treated patients.">
        <entity charOffset="62-69" id="DDI-DrugBank.d186.s6.e0" text="rifampin" type="drug"/>
        <entity charOffset="106-116" id="DDI-DrugBank.d186.s6.e1" text="haloperidol" type="drug"/>
        <pair ddi="true" e1="DDI-DrugBank.d186.s6.e0" e2="DDI-DrugBank.d186.s6.e1" id="DDI-DrugBank.d186.s6.p0" type="advise"/>
    </sentence>
</document>